文献速递药物不良反应与药物警戒

爱尔兰药物相关诉讼六年回顾分析

Medication related litigation in Ireland: A 6-year review.
PubMed 文献 · Br J Clin Pharmacol · 2019-07-23

该研究检索爱尔兰国家事件管理系统,分析2011至2016年最终结案的药物相关索赔,识别最常见涉诉药物及诉讼成本。

要点

  • 用药错误仅发生于给药和处方阶段,给药阶段占58%。
  • 赔付索赔涉及药物以全麻药、阿片类、青霉素类、抗血栓药和局麻药为主。

核心结论

  • 该研究将药物事件、患者实际伤害与诉讼成本数据关联,全面呈现了用药错误的后果。

研究设计与样本

  • 检索爱尔兰国家事件管理系统,纳入2011至2016年最终结案的药物相关索赔,并调取纸质案卷提取补充数据。

主要发现

  • 共识别79例相关索赔,其中48例以向原告赔付结案,这48例涉及54种药物。
  • 涉诉药物组包括全麻药(n=7)、阿片类(n=6)、青霉素类、抗血栓药和局麻药(均n=5)。
  • 用药错误仅发生于给药阶段(58%)和处方阶段(42%)。
  • 药物事件类型包括剂量/强度错误(n=17)、药物错误(n=7)和药物不良反应(n=6)。
  • 最常诉请的主要伤害为过敏反应(n=9)、临床状况恶化(n=9)和创伤后应激障碍(n=8)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The primary aims of the study were to identify those medications most frequently associated with clinical litigation in Ireland and to quantify the cost of such litigation. Secondary aims were to identify where in the medication-use process claims were most likely to arise, the medication incident types involved and the primary injury alleged. METHODS: The National Incident Management System (NIMS) for incident and claims management was searched to identify all medication-related claims finalised from 2011 to 2016 (inclusive). The physical case files were obtained and additional data not available on NIMS was extracted in order to build a detailed picture of the incident and subsequent claim. RESULTS: The search identified 79 relevant claims, of which 48 closed with a payment to the plaintiff. These 48 claims involved 54 medications. Medication groups identified included general anaesthetics (n = 7), opioids (n = 6), penicillins, antithrombotics and local anaesthetics (all n = 5). The errors alleged occurred exclusively at the administration (58%) and prescribing (42%) stages of the medication-use process. Medication incident types included wrong dose/strength (n = 17), wrong drug (n = 7) and adverse drug reaction (n = 6). The most commonly pleaded primary injuries were allergic reaction (n = 9), deterioration in clinical status (n = 9) and post-traumatic stress disorder (n = 8). The median total cost of these claims was €60 991, including median damages of €33 858. CONCLUSIONS: This study links data on medication incidents, actual harm to patients and litigation costs. Thus, it presents a comprehensive picture of the consequences of medication error.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. McCullagh M, Slattery D. Medication related litigation in Ireland: A 6-year review. Br J Clin Pharmacol. 2019. PMID: 31219195. doi:10.1111/bcp.14035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。